Abstract
Arginine-vasopressin (AVP) caused a marked shape change reaction and rise in [Ca2+]i in human blood platelets only when the extracellular buffer contained Mg2+ or Ca2+. At physiological concentrations of the cations the potency of AVP was higher in the presence of Mg2+ than of Ca2+. The amplitude of the shape change reaction was also greater with Mg2+ than with Ca2+, although the [Ca2+]i-rise was slightly more marked with extracellular Ca2+. The concentration of Mg2+ at which AVP showed half of its maximal effects was below the physiological plasma level of the cation, whereas the corresponding value for Ca2+ was higher. Addition of Ca2+ to the Mg2+ containing medium did not further enhance the action of AVP on platelet shape. In platelet-rich plasma the potency and efficacy of AVP in causing a shape change were similar in the presence and absence of EGTA, whereas with EDTA in the medium AVP had no effect. In conclusion, Mg2+ has an essential physiological role in AVP-induced platelet activation, which is brought about partly by release of intracellular calcium and partly by some other intracellular mechanism.
MeSH Terms
Arginine Vasopressin/pharmacology
Blood Platelets/cytology,drug effects,metabolism
Calcium/blood
Edetic Acid/pharmacology
Humans
In Vitro Techniques
Magnesium/blood,physiology
Receptors, Angiotensin/physiology
Receptors, Vasopressin
Chemicals
Receptors, Angiotensin
Receptors, Vasopressin
Arginine Vasopressin
Edetic Acid
Magnesium
Calcium
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Erne P
Pletscher A
References (13)
13 references, click to expand
-
Shape change and uptake of 5-hydroxytryptamine in human blood platelets: action of neuropsychotropic drugs.
Life Sci. 1979 May 14;24(20):1833-40
PMID: 459685
-
Chemistry and structure-activity relations of the antidiuretic hormones.
Am J Med. 1967 May;42(5):653-77
PMID: 5337371
-
Vasopressin and angiotensin II receptors in rat aortic smooth muscle cells in culture.
Am J Physiol. 1983 Jan;244(1):E72-82
PMID: 6295182
-
Measurement of receptor induced changes in intracellular free calcium in human platelets.
J Recept Res. 1984;4(1-6):587-604
PMID: 6098672
-
Divalent cation requirements for aggregation of human blood platelets and the role of the anti-coagulant.
Thromb Res. 1979;14(4-5):713-27
PMID: 113902
-
The nature of the hepatic receptors involved in vasopressin-induced glycogenolysis.
Biochim Biophys Acta. 1979 Nov 15;588(1):63-9
PMID: 227475
-
Vasopressin and memory.
Pharmacol Ther. 1983;20(3):437-58
PMID: 6351117
-
Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets.
Naunyn Schmiedebergs Arch Pharmacol. 1984 Apr;325(4):337-42
PMID: 6427633
-
Aggregation of human blood platelets by vasopressin.
Am J Physiol. 1972 Oct;223(4):958-67
PMID: 4342380
-
The role of cytoplasmic free calcium in the responses of quin2-loaded human platelets to vasopressin.
Biochem J. 1984 Aug 1;221(3):897-901
PMID: 6433890
-
Localization and characterization of vasopressin-binding sites in the amygdala of the rat brain.
J Neurosci. 1984 Jul;4(7):1764-70
PMID: 6330316
-
Effects and subcellular distribution of magnesium in smooth and striated muscle.
Fed Proc. 1981 Oct;40(12):2667-71
PMID: 7026293
-
Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca-independent activation for shape-change and secretion.
FEBS Lett. 1982 Nov 1;148(1):21-6
PMID: 6816632